Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNE1 | P24864 | 7/20 | 0.45 |
| ▸ | CDK2 | P24941 | 7/20 | 0.45 |
| ▸ | CCNE2 | O96020 | 4/20 | 0.45 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.45 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.45 |
| ▸ | CDK1 | P06493 | 6/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.36 |
| ▸ | NT5E | P21589 | 3/20 | 0.36 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.34 |
| ▸ | CLK1 | P49759 | 1/20 | 0.34 |
| ▸ | CLK2 | P49760 | 1/20 | 0.34 |
| ▸ | CDK7 | P50613 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL238900 | 0.93 | CDK2 (0.37) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| Trifluoroacetic Acid SCHEMBL4131725 | 0.91 | CCNE1 (0.48) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| SCHEMBL4123531 | 0.90 | CCNE1 (0.36) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| SCHEMBL1412172 | 0.88 | NT5E (0.42) | ADORA2AADORA3NT5E | |
| SCHEMBL4127533 | 0.88 | CCNE1 (0.50) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| SCHEMBL4111351 | 0.85 | ADORA2A (0.38) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| SCHEMBL1402142 | 0.85 | ADORA2A (0.40) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| SCHEMBL10155775 | 0.85 | CCNE2 (0.43) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| SCHEMBL10156310 | 0.85 | CCNE2 (0.43) | CCNE1CDK2CCNE2CCNA2CCNA1 | |
| Trifluoroacetic Acid SCHEMBL238899 | 0.84 | ADORA2A (0.41) | CCNE1CDK2CCNE2CCNA2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090099214-A1 | Organic Compounds | NOVARTIS AG | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099214-A1 | Organic Compounds | CYP3A43, OXER1, OPRM1 | CCNE1 267/4885CDK2 886/4885CCNE2 444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.